ONJCRI researchers and collaborators at @unimelb.bsky.social and RMIT have developed a novel nanomedicine delivery system with highly ordered structures that enhance cargo delivery to their targets. ➡️ Read the paper: ow.ly/XmYX50X1j4I #LipidNanoparticles #Nanomedicine #CancerResearch

Today, we celebrate World Cancer Research Day, a recognition of the vital role of research in improving cancer outcomes and reducing the global cancer burden. ➡️ Learn more about our research: www.onjcri.org.au/ou... #WorldCancerResearchDay

We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.

Researchers at ONJCRI, the University of Washington and @wehi-research.bsky.social have created novel "designer proteins" that can both activate and block cell death as required under different conditions. ➡️ Read the Science Advances paper: ow.ly/5glk50WSRnT #CellDeath #Apoptosis #ONJCRI

Researchers at ONJCRI, @wehi-research.bsky.social and @petermaccc.bsky.social have discovered that a known protein complex can stop a common type of blood cancer in its tracks. The findings were published in @natcomms.nature.com ➡️ Read more: ow.ly/Ca4S50WHVrA #Lymphoma #CRISPR

📚 Congratulations to Dr Sarah Yeo, lead author of TRACKER Biobank's first peer-reviewed publication, which explores the challenges and future directions for lung cancer biobanking in Australia. Read the review here: ow.ly/jlvA50Wze5Y #LungCancerResearch #CancerResearch #Biobank #ONJCRI

Today, we stand with patients, families, clinicians, and researchers to raise awareness of lung cancer. - 36 Australians are diagnosed with lung cancer each day - Lung cancer claims the most lives of any cancer in Australia - Less than 6% of cancer research funding is allocated to thoracic cancers

Bowel cancer rates are rising in young people, and researchers are working tirelessly to find out why, writes Dr Lisa Mielke buff.ly/SpTGiBQ @onjcri.org.au @lisa-mielke.bsky.social

🎗️ This World Head and Neck Cancer Day, we're highlighting ONJCRI's START-HN trial: a game-changing combination of precision radiotherapy and revolutionary immune monitoring techniques that can track how immune cells respond to treatment. Read more here: ow.ly/el1V50WvBBy

We are thrilled to share that the ACRF Centre for Precision Medicine has officially opened at ONJCRI. Thank you to ACRF for making this new facility become a reality. ➡️ Read more about our new Centre: ow.ly/mcJl50WtK57 #ACRF #CancerResearch #PrecisionMedicine #ONJCRI

💡 Breakthrough in rare cancer care Research led by Prof Eliza Hawkes shows that 3D imaging can revolutionise how we monitor treatment for primary central nervous system lymphoma (PCNSL), a rare but aggressive cancer. Read the full study here: ow.ly/Nler50WqYMI

🧠 This Glioblastoma (GBM) Awareness Day, we highlight The Centre for Research Excellence in Brain Cancer's Biomarkers in Brain project. "This valuable resource will allow us to push forward with research to find better treatments for GBM patients.” ➡️ Learn more: ow.ly/NFAm50Wqiel

Congratulations to Dr Lisa Mielke, who received a prestigious Australian Research Council (ARC) Future Fellowship totalling $1.13 million to research new molecules for future drug and vaccine development. ➡️ Learn more: ow.ly/GSAP50Wo6L1 #FutureFellowship #ONJCRI

🎯 Game-changer for lymphoma treatment ONJCRI researchers have cracked the code on predicting which blood cancer patients will respond best to a powerful combo of radiotherapy and immunotherapy. In @bloodjournals.hematology.org Read more on our website: ow.ly/CnZc50Wo6gw #Cancer #Lymphoma

The first publication from our rare cancers clinical trial (MoST CIRCUIT) was published in‪ @jamaoncology.com‬. Congratulations to A/Prof Oliver Klein and team! Read more: ow.ly/gr8O50Wnnxv Thank you to @bms-news.bsky.social, Omico, and the Minderoo Foundation.

Congratulations to ‪@davidyiju.bsky.social‬ who has received funding through TIA’s Pipeline Accelerator program. The funding will allow Dr Ju, Dr Shiyao Li and Prof Marco Herold to work with the BASE mRNA facility to pursue research on mRNA-based immunotherapies. ➡️ ow.ly/30yH50Wm72I

New research on MCL-1 by WEHI and ONJCRI's Prof Marco Herold published in Science. Read more ⬇️

New research: MCL-1 not only prevents cell death, also fuels cells by supporting energy production. Helps explain side effects seen with MCL-1 targeting drugs in cancer clinical trials; could lead to better therapies. In @science.org 🔗 www.wehi.edu.au/news/hidden-...

Congratulations to Professor Andrew Scott AM who received two awards at the SNMMI meeting last week. ➡️ The Minoshima-Pappas award ➡️️ The Henry Wagner Jr lecture award Read more: ow.ly/ExHa50WkR3C @snm-mi.bsky.social‬ #SNMMI2025 #NuclearMedicine #Theranostics #ONJCRI

Relive the highlights of the launch of our Impact Strategy 2025–2029! Thank you to everyone who attended, shared insights, and celebrated this milestone with us. #EffectiveTolerableAccessible #ImpactStrategy #BedsideToBenchToBedside #ONJCRI youtu.be/M3U-RnVz5Qw

Unlocking the immune system to eliminate breast cancer 🔬 Dr Chamikara Liyanage uses single-cell genomics to uncover how tumours evade detection. His breakthrough? A nutrient-immune pathway that may restore immune function in aging tissue. 🔗 ow.ly/BHhw50WiNa9

🎉 Congratulations to Dr Lisa Mielke, who has been awarded a grant totalling US$310,000 by the Colorectal Cancer Alliance Project Cure CRC initiative. Read more: ow.ly/K6Rc50VKYnp #ColorectalCancer #CancerResearch #ONJCRI

After losing her sister Han to brain cancer, Molly is running the Surf Coast Century to raise funds for research at ONJCRI. 🏃‍♀️ “Every sunrise brings me closer to Han.” 👉 Let’s support Molly and make every step count: ow.ly/GlfS50Wff9I

🎗️ Rare Cancers Awareness Day 🌏 🧬 Dr Quentin Gouil utilises cutting-edge gene sequencing and bioinformatics to help our scientists obtain a rapid and comprehensive view of the inner workings of a tumour cell. Learn more here: ow.ly/FiTK50WgvrZ #RareCancers #Genomics #ONJCRI

💛 Cancer research breakthroughs give patients the gift of more time. 🔬This EOFY, click here and learn about how The John Brumby Impact Fund supports bold cancer research at the Olivia Newton-John Cancer Research Institute: ow.ly/HUhx50WcEna #EOFY #Cancer #Research #ONJCRI #survivor

🔬 #ClinicalTrial spotlight 💊 The TOP-FLOR clinical trial, led by ONJCRI’s Chief Clinical Research Officer @elizahawkes.bsky.social, is exploring a new treatment for people newly diagnosed with Follicular Lymphoma. ➡️ Read more here: ow.ly/B04850W9OqO#ClinicalTrial #Lymphoma #oncology #HemeSky

We are delighted to announce our new John Brumby Impact Fund (JBIF), providing competitive grants to ONJCRI researchers to support bold, patient-focused research with strong potential for clinical application.   ➡️ Learn more: ow.ly/c3Ac50W8N3u #EffectiveTolerableAccessible

ONJCRI is proud to share its new Impact Strategy 2025–2029, a framework to drive innovative and patient-centred research that translates to cancer treatments sooner. ➡️ Learn more: ow.ly/2aLz50W7v2S #EffectiveTolerableAccessible #CancerResearch #ONJCRI

Congratulations to our Clinician-Scientist Professor Andrew Scott AM, who played a key role in drafting a resolution on medical imaging that was adopted by ‪@who.int‬ last week. ➡️ Read our article here: ow.ly/5vw050W4whW #MedicalImaging #WorldHealthAssembly

📚 Congratulations to Dr Yi (David) Ju who received the Editorial Contribution Award and Author Service Award from ‪@springernature.com‬. These awards are a recognition of Dr Ju's contributions as an Editor for the Journal of Materials Science. #ONJCRI #ScientificJournal

📣 We are delighted to share our 2024 Annual Report: www.onjcri.org.au/ab... 💛 The stories and breakthroughs featured in the report reflect our team's dedication to creating a future where cancer treatment is more effective, tolerable and accessible for all. #AnnualReport #ONJCRI

Congratulations to Sakshi Arora, Prof Andrew Scott AM and A/Prof Peter Janes whose review paper on ADAM metalloproteases was published in Cancers this week. ➡️ Read the article to learn more about ADAMs: ow.ly/2YHG50VW5vk #ADAMmetalloproteases #CancerResearch #ONJCRI

🔬 New publication! Congrats to PhD student Juliani Juliani on her paper in Autophagy Reports, revealing BECLIN1's key role in gut health. Loss of BECLIN1 causes fatal inflammation - highlighting vital functions beyond autophagy. 📄 Read more: ow.ly/6giG50VVl7s

Excited to speak at the Controlled Release Society (CRS) Local Chapter webinar on 21 May! ⏰ 8-10 AM UTC | 10 AM-12 PM CET | 6-8 PM AEST. My talk: From fundamental bio-nano interactions to mRNA vaccines & therapeutics. Free to join 👉Zoom Link: us06web.zoom.us/j/81945385019 Meeting ID: 819 4538 5019

🧬 Meet the talented team behind the Melbourne Advanced Gene Editing Centre (MAGEC), who generate sophisticated pre-clinical models allowing #ONJCRI to make strides in its cancer research. ➡️ ow.ly/jZtx50VLL2h#ONJCRI#CRISPR MAGEC is supported by Phenomics Australia and NCRIS.

📕 New in Nature Nanotechnology! Congratulations to our very own Dr Yi (David) Ju and Dr Stephen Kent from the Peter Doherty Institute on their comment in Nature Nanotechnology, exploring how balancing stealth and targeting can boost the impact of nanomedicines. 👉 ow.ly/bzGx50VRGqX

A major breakthrough in breast cancer research! 🧬🩸 ONJCRI-led study shows immune cells in blood can reveal how far breast cancer has spread - paving the way for a simple blood test to detect metastasis. Proudly supported by the Vic Cancer Agency. 📖 Read more: doi.org/10.1186/s130...

🎉 Grant News 🎉 Congrats to Prof Andrew Scott AM on receiving nearly $700K from the @NBCF for research into novel antibody-drug conjugates to treat aggressive breast cancer, incl. HER2+ & triple-negative types. Read more 👉 ow.ly/JPEc50VGGk5

🧠 Brain Cancer Awareness Month ✨ This May, we spotlight Prof Hui Gan and his new Cancer Therapies & Biology Lab, advancing brain cancer research. "We are at a pivotal moment in Australia. We have a real opportunity to fast-track progress & change lives.” Learn more: ow.ly/qAt950VNnxY

🎉 Huge congratulations to our 2024 ONJCRI PhD student cohort - now confirmed candidates! Your hard work shines, and we can’t wait to see what’s next. - Sarah Yeo - Andrew Li - Birhanu Jemere - Purva Trivedi - Ellie Ritchie - Katherine Eljammas - Maede Salehi - Kiru Raghunathan - Biswadeep Sen

🧬 Researchers at ONJCRI and WEHI have determined that a specific DNA mutation in DNMT3A can weaken a major tumour-suppression pathway in blood stem cells. Read more about the research which was published in @emboreports.org today: ow.ly/xLAp50VK6r5 #DNMT3A #AML

✨ New Publication! ✨ ONJCRI’s Josh Konecnik & Dr Moritz Eissmann recently published a powerful new protocol to better model gastric cancer, fast-track treatments & uncover new targets. 👏 Big congrats to the team! 🔗 ow.ly/UUbW50VGHh8

Today is World DNA Day, a celebration of the discovery of DNA and of the scientific advances that our understanding of DNA has made possible. ➡️ Read insights from Dr Conor Kearney on the link between DNA and cancer in our latest website article: ow.ly/9nSB50VBnzx #DNADay #ONJCRI

A review about CRISPR Activation Technology by Dr Eddie La Marca, Professor Marco Herold, and colleagues from @wehi-research.bsky.social, has been published in the Annual Review of Cancer Biology. Congratulations to the authors! 🧬 Read the review: ow.ly/9YjS50VAxlU #CRISPR #ONJCRI

📣 The ONJCRI 10-Year Anniversary Conference Meeting Report is now published in Cell Death & Disease! Dive into the highlights of “A Decade of Cancer Research and Translation” and celebrate our progress. 👏 Huge thanks to the authors! 🔗 ow.ly/1PTA50VAyT3

🎉 Congratulations to Prof Hui Gan for being awarded a significant Medical Research Future Fund grant to pursue an important study into glioblastoma. 🧠 The team hope to identify new treatment avenues for this type of brain cancer. Read more: ow.ly/TW5850VxV4x #braincancer #glioblastoma

🔬 Meet Dr Sarah Yeo, a clinician PhD student at ONJCRI! 🌟 As a respiratory specialist, Dr Yeo is tackling immunotherapy resistance in lung cancer. Using TRACKER biobank samples, her research aims to identify biomarkers for better treatment and improved patient outcomes.

ONJCRI supports @aamri.bluesky.social in its call for increased investment into medical research to secure the future of this vital industry. ➡️ Learn more: ow.ly/3gRT50Vx49w #StandupforScience2025 #AAMRI2025ElectionStatement #Election2025

Supercharging Discovery✨ Thanks to a generous benefactor, ONJCRI has boosted its cancer research capabilities with two cutting-edge imaging platforms — the Phenocycler Fusion & Phenoimager HT — offering unprecedented insight into the tumour microenvironment. A leap toward personalised medicine. 💥

✨ Celebrating a Major Publication Milestone! ✨ Congratulations to Dr Andrew Guirguis on the first publication from his ONJCRI lab! His review in Experimental Hematology explores RNA methylation in blood cancers & its therapeutic potential. 📖 Read more: ow.ly/otQk50VtyJc